Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Valproate sodium - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for valproate sodium and what is the scope of patent protection?

Valproate sodium is the generic ingredient in two branded drugs marketed by Abbvie, Athenex Inc, Fresenius Kabi Usa, and Hikma Farmaceutica, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for valproate sodium. Two suppliers are listed for this compound.

Recent Clinical Trials for valproate sodium

Identify potential brand extensions & 505(b)(2) entrants

Virginia Commonwealth UniversityPhase 1/Phase 2
Puma Biotechnology, Inc.Phase 1/Phase 2
Elizabeth ThielePhase 3

See all valproate sodium clinical trials

US Patents and Regulatory Information for valproate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DEPACON valproate sodium INJECTABLE;INJECTION 020593-001 Dec 30, 1996 DISCN Yes No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa VALPROATE SODIUM valproate sodium INJECTABLE;INJECTION 076539-001 Jun 26, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
Athenex Inc VALPROATE SODIUM valproate sodium INJECTABLE;INJECTION 076295-001 Nov 14, 2002 AP RX No No   Start Trial   Start Trial   Start Trial
Hikma Farmaceutica VALPROATE SODIUM valproate sodium INJECTABLE;INJECTION 078523-001 Feb 17, 2010 AP RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.